Search

everythinglearnresearchcommunity

for

Search:↓

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Finasteride may cause infertility in rats by affecting epididymis and sperm function.

Finasteride doesn't change polycystic ovary size or cyst number, suggesting testosterone's role in their appearance.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Massaging the scalp with a cosmetic containing certain natural inhibitors can significantly regrow hair in men with pattern baldness.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

More research needed to confirm finasteride as standard treatment for FFA.

The document discusses new insights into how hormones affect male sexual health and related conditions.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Perifollicular fibrosis hinders hair regrowth in androgenetic alopecia, and new treatments targeting fibrosis are needed.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Finasteride effectively treats male hair loss, with oral and topical forms improving hair growth, but oral use may have side effects.

Dutasteride mesotherapy for hair loss can cause lasting bald patches.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

Finasteride is not proven to cause depression or suicide, and careful patient monitoring is advised.